GLP-1 users are everywhere. Study-qualified GLP-1 patients are not.
Need verified GLP-1 patients for a healthcare research study? Focus Insite helps research teams recruit hard-to-find GLP-1 cohorts for paid studies including discontinued users, switchers, compounded users, branded users, self-pay users, and payer-denied patients.
The recruit looks easy until the protocol gets specific.
GLP-1 research is moving fast. But a broad “GLP-1 user” is not the same as a verified, study-qualified patient who matches your protocol and shows up ready to participate.
- discontinued users
- compounded-to-branded switchers
- self-pay patients
- payer-denied patients
- branded medication users
- dose-specific patients
- patients with comorbidities
- cost, side-effect, access & switching interviews
The market got bigger. The recruit got harder.
GLP-1 usage has created massive demand for patient research. But growth does not make every cohort easy to recruit. Branded medications, compounded alternatives, discontinuation, switching, cost pressure, payer restrictions, and side effects have made the patient landscape messy.
The real question is not:
“Can we find GLP-1 users?”
The real question is:
“Can we find the exact GLP-1 patients this study needs and trust that they are real?”
Verified GLP-1 patients for high-stakes healthcare research.
Go beyond broad panel labels. Focus Insite recruits against actual patient behavior, medication status, and payer profile.
Current GLP-1 users
Patients currently using GLP-1 medications for obesity, diabetes, or related health needs.
Discontinued users
Patients who stopped due to cost, side effects, access, frustration, plateau, or other barriers.
Compounded users
Patients using or recently using compounded semaglutide or tirzepatide pathways.
Branded users
Patients using Ozempic, Wegovy, Mounjaro, Zepbound, or similar branded medications.
Switchers
Patients who moved between compounded and branded, or switched medications/providers.
Self-pay users
Patients paying out of pocket dealing with price sensitivity, loyalty, and churn risk.
Payer-denied patients
Patients affected by insurance denial, prior authorization, or coverage barriers.
Have a protocol-specific GLP-1 cohort? We’ll review feasibility on the discovery call.
Recruitment clarity before the timeline becomes the problem.
- 1
Recruit verified GLP-1 patients
Find real, qualified patients who match the study’s criteria.
- 2
Reach discontinued users & switchers
Go beyond broad panel labels and recruit against actual patient behavior.
- 3
Reduce fake respondent & fraud risk
Protect the study from incentive-driven fakes and unqualified participants.
- 4
Avoid missed quotas & delayed fielding
Identify recruitment complexity early and build a smarter fielding plan.
- 5
Clear feasibility before launch
Understand what is realistic before committing to the client or sponsor.
How Focus Insite helps reduce GLP-1 recruitment risk.
A repeatable five-step process for feasibility, sourcing, verification, and delivery.
- STEP 1
Review the Study
Audience, sample size, timeline, geography, and research method.
- STEP 2
Define the Exact Cohort
Medication status, usage behavior, payer/access profile, discontinuation, switching, and screening criteria.
- STEP 3
Source and Screen
Recruit against the specific study profile, not a generic “GLP-1 user” label.
- STEP 4
Verify and Confirm
Human screening, consistency checks, confirmation, and communication to reduce bad-fit respondents.
- STEP 5
Deliver Study-Ready Participants
Qualified, confirmed participants with project visibility and daily communication.
Built for hard-to-find humans.
Focus Insite has spent more than a decade helping research teams find specific people for specific studies from patients and caregivers to B2B decision-makers, consumers, medical professionals, and hard-to-reach research audiences.
- Medical patient recruiting experience
- Hard-to-reach participant sourcing
- Nationwide recruitment infrastructure
- Verified human approach
- Qualitative research recruitment expertise
- Human screening & confirmation
- Daily project communication
- Experience with high-stakes audiences
“Your insight is only as good as the people giving it.”
Award-winning. Independently verified. Trusted by Fortune 100 clients.
A decade of recognition for growth, culture, and delivering research-grade recruitment for the healthcare industry's most demanding buyers.
2x Inc. 5000
Top 0.4% of U.S. companies
Soaring 76
Fastest-growing companies in Philadelphia
Certified Great Place to Work
Independently verified culture
Quartz Best Companies
Best for Remote Workers
Titan 100 CEO
Philadelphia
Preferred Vendor
Trusted by Fortune 100 clients
Book a GLP-1 Discovery Call.
Tell us what kind of GLP-1 patients you need, what makes the recruit difficult, and when fielding needs to happen. We’ll use the call to determine if Focus Insite can help recruit your exact cohort.
What we’ll review:
- patient cohort
- study type
- sample size
- fielding timeline
- geography
- screener criteria
- fraud or verification concerns
- current vendor status
- recruitment risks
- next best step
Questions healthcare research teams ask before a GLP-1 recruit.
This page is for healthcare market research agencies, pharma insights teams, CROs, telehealth companies, and research teams that need GLP-1 patients for paid studies.
The longer you guess, the more timeline risk you create.
A GLP-1 recruit can look simple on paper and become expensive in field. Fake respondents, unclear cohort definitions, missed feasibility assumptions, and no-shows can turn a promising study into a client-confidence problem.
The best time to review the recruit is before the study breaks.
Need verified GLP-1 patients for a paid healthcare study?
Book a discovery call and let’s see if Focus Insite can recruit your exact cohort.
Built for healthcare research teams that need real patients, clean recruiting, and fewer fieldwork surprises.